Hypertension and dementia

Current Cardiology Reports

Volumn 5, Issue 6, 2003, Pages 435-440

  Hanon, Olivier ^a   Seux, Marie Laure ^b   Lenoir, Hermine ^b   Rigaud, Anne Sophie ^b   Forette, Françoise ^b  

^a Paris Descartes University   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRENDIPINE;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BRAIN INFARCTION; BRAIN MICROCIRCULATION; BRAIN VENTRICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DRUG PENETRATION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; NONHUMAN; PATHOGENESIS; RAT; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; WHITE MATTER; PATHOPHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; DEMENTIA; HUMANS; HYPERTENSION;

EID: 1542780835     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0104-2     Document Type: Review

References (49)

1. Snowdon DA, Greiner LH, Mortimer JA, et al.: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
2. Elias MF, Wolf PA, d'Agostino RB, et al.: Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993, 138:353-364.
3. Launer J, Masaki K, Petrovitch H, et al.: The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846-1851.
4. Kilander L, Nyman H, Boberg M, et al.: Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998, 31:780-786.
5. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A: Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 1999, 53:1948-1952.
6. Knopman D, Boland LL, Mosley T, et al., and the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42-48.
7. Okumiya K, Matsubayashi K, Wada T, et al.: J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan. J Am Geriatr Soc 1997, 45:1032-1033.
8. Glynn RJ, Beckett LA, Hebert LE, et al.: Current and remote blood pressure and cognitive decline. JAMA 1999, 281:438-445.
9. Bohannon AD, Fillenbaum GG, Pieper CF, et al.: Relationship of race/ethnicity and blood pressure to change in cognitive function. J Am Geriatr Soc 2002, 50:424-429.
10. Cacciatore F, Abete P, Ferrara N, et al.: Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998, 46:1343-1348.
11. Skoog I, Lernfelt B, Landahl S, et al.: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
12. Guo Z, Viitanen M, Fratiglioni L, Winblad B: Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996, 312:805-808.
13. Launer LJ, Ross GW, Petrovitch H, et al.: Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000, 21:49-55.
14. Kivipelto M, Helkala EL, Laakso MP, et al.: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322:1447-1451.
15. Qiu C, Winblad B, Viitanen M, Fratiglioni L: Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke 2003, 34:594-599.
16. Meyer JS, Judd BW, Tawaklna T, et al.: Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986, 256:2203-2209
17. Guo Z, Fratiglioni L, Zhu L, et al.: Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999, 56:991-996.
18. Murray MD, Lane KA, Gao S, et al.: Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 2002 ,162:2090-2096.
19. Prince MJ, Bird AS, Blizard RA, Mann AH: Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996, 312:801-805.
20. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264
21. Di Bari M, Pahor M, Franse LV, et al.: Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001, 153:72-78.
22. Forette F, Seux M-L, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351.
23. Forette F, Seux ML, Staessen JA, et al., for the Systolic Hypertension in Europe Investigators: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002 ,162:2046-2052.
24. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041.
25. Tzourio C, Anderson C, Chapman N, et al., for the PROGRESS Collaborative Group: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003 12,163:1069-1075.
26. O'Neill C, Cowburn RF, Bonkale WL, et al.: Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 2001, 67:177-194.
27. Pascale A, Etcheberrigaray R: Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. Pharmacol Res 1999, 39:81-88.
28. Gould RJ, Murphy KM, Snyder SH: Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine. Brain Res 1985, 330:217-223.
29. Lopez-Arrieta JM, Birks J: Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2002, 3:CD000147.
30. Lithell H, Hansson L, Skoog I, et al., for the SCOPE Study Group: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21:875-886.
31. Bulpitt C, Fletcher A, Beckett N, et al.: Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging 2001, 18:151-164.
32. Strandgaard S, Paulson OB: Cerebrovascular consequences of hypertension. Lancet 1994, 344:519-520.
33. Tatemichi TK, Desmond DW, Mayeux R, et al.: Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992, 42:1185-1193.
34. Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al.: Clinical determinants of poststroke dementia. Stroke 1998, 29:75-81.
35. Andersen G, Vestergaard K, Riis J, Ingeman-Nielsen M: intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis 1996, 6:363-369.
36. Tatemichi TK, Paik M, Bagiella E, et al.: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994, 44:1885-1891.
37. Kokmen E, Whisnant JP, O'Fallon WM, et al.: Dementia after ischemic stroke. A population based study in Rochester, Minnesota (1960-1984). Neurology 1996, 46:154-159.
38. Henon H, Pasquier F, Durieu I, et al.: Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997, 28:2429-2436.
39. Longstreth WT Jr, Manolio TA, Arnold A, et al.: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996, 27:1274-1282.
40. Breteler MMB, van Swieten JC, Bois ML, et al.: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994, 44:1246-1252.
41. Hardy JA, Mann DM, Wester P, Winblad B: An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986, 7:489-502.
42. Hamet P, Richard L, Dam TV, et al.: Apoptosis in target organs of hypertension. Hypertension 1995, 26:642-648.
43. Vagnucci AH Jr, Li WW. Alzheimer's disease and angiogenesis. Lancet 2003, 361:605-608.
44. Arregui A, Perry EK, Rossor M, Tomlinson BE: Angiotensin converting nzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J Neurochem 1982, 38:1490-1492.
45. Kokmen E, Beard CM, Chandra V, et al.: Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991, 41:1393-1397.
46. Prince M, Cullen M, Mann A: Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994, 44:97-104.
47. Sparks DL, Scheff SW, Liu H, et al.: Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995, 131:162-169.
48. Yoshitake T, Kiyohara Y, Kato I, et al.: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45:1161-1168.
49. Morris MC, Scherr PA, Hebert LE, et al.: Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001, 58:1640-1646.